ab-101
Cell therapyexperimental
Clinical trial activity
7 trials · 7 clinical orgs · 0 marketing orgs
Phase 1
5
Phase 2
3
Phase 3
0
Phase 4
0
Earliest trial started Jul 9, 2018 (NCT03592121)
Timeline
Indications
Studied for
- Arthritis, Rheumatoid · Phase 1
- Breast Neoplasms · Early Phase 1
- Dermatitis, Atopic · Phase 2
- Eczema · Phase 2
- Granulomatosis with Polyangiitis · Phase 1
- Hepatitis B, Chronic · Phase 1
- Hodgkin Disease · Phase 2
- Lupus Erythematosus, Systemic · Phase 1
- Lupus Nephritis · Phase 1
- Lymphoma, Non-Hodgkin · Phase 1/Phase 2
- Lymphoma, T-Cell, Peripheral · Phase 2
- Nipples · Early Phase 1
- Pemphigus · Phase 1
- Peripheral Nerve Injuries · Early Phase 1
- Sexual Dysfunction, Physiological · Early Phase 1
- Sexual Dysfunctions, Psychological · Early Phase 1
Mechanism of action
- Tumor antigensImmunity, passive
immunity, passive - tumor antigens
Chemistry & pharmacology
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL4297681 ↗
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06855745 | Phase 2 | Mar 10, 2025 | Alphyn Biologics |
| NCT06581562 | Phase 1 | May 15, 2024 | Artiva Biotherapeutics, Inc., Iris Pharma |
| NCT06265220 | Phase 1 | Apr 3, 2024 | Artiva Biotherapeutics, Inc. |
| NCT05883449 | Phase 2 | Oct 10, 2023 | Affimed GmbH, Artiva Biotherapeutics, Inc. |
| NCT05960240 | Phase 1 | Sep 30, 2023 | Arbutus Biopharma Corporation |
| NCT04673617 | Phase 1/Phase 2 (Phase 2) | Dec 29, 2020 | Artiva Biotherapeutics, Inc. |
| NCT03592121 | Early Phase 1 (Phase 1) | Jul 9, 2018 | Applied Biology, Inc., Southern California Center for Sexual Health and Survivorship Medicine |
Showing 7 of 7 trials
Page 1 / 1
Organizations
Research & Development (7)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Artiva Biotherapeutics, Inc. | For profit | 4 | 2 | 2 | 2020 |
| Affimed GmbH | For profit | 1 | 1 | 1 | 2023 |
| Alphyn Biologics | For profit | 1 | 1 | 1 | 2025 |
| Applied Biology, Inc. | For profit | 1 | 1 | 1 | 2018 |
| Arbutus Biopharma Corporation | For profit | 1 | 1 | 1 | 2023 |
| Iris Pharma | For profit | 1 | 1 | 1 | 2024 |
| Southern California Center for Sexual Health and Survivorship Medicine | Academic/Hospital | 1 | 0 | 1 | 2018 |
7 organizations
Page 1 / 1